[Reorganization of public health services and regional problems in health care].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3669429)

Published in Hokenfu Zasshi on July 01, 1987

Authors

S Hino

Articles by these authors

Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch (1974) 3.24

DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol (1999) 3.17

Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol (1976) 2.82

Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol (1999) 2.13

Amplification and detection of a single molecule of human immunodeficiency virus RNA. Virus Genes (1993) 1.53

Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res (1985) 1.53

Use of the curved linear-array echo endoscope to identify gastrorenal shunts in patients with gastric fundal varices. Endoscopy (2004) 1.44

Population dynamics of phenol-degrading bacteria in activated sludge determined by gyrB-targeted quantitative PCR. Appl Environ Microbiol (1998) 1.42

Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest (1993) 1.38

Immunological cross reactivity of Mason-Pfizer monkey virus with type C RNA viruses endogenous to primates. Nature (1976) 1.37

Course and outcome of tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis (1999) 1.35

Antigenic determinants of the 70,000 molecular weight glycoprotein of woolly monkey type C RNA virus. J Immunol (1975) 1.35

Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Proc Natl Acad Sci U S A (1977) 1.30

Differential expression of helper viral structural polypeptides in cells transformed by clonal isolates of woolly monkey sarcoma virus. J Virol (1975) 1.22

Polyadenylate in the virion RNA of mouse hepatitis virus. J Biochem (1977) 1.21

A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf activation and axis formation. J Biol Chem (2000) 1.20

Degree of immunity induced by killed vaccines to experimental salmonellosis in mice. Infect Immun (1972) 1.15

Feedback inhibition of amidophosphoribosyltransferase regulates the rate of cell growth via purine nucleotide, DNA, and protein syntheses. J Biol Chem (2001) 1.14

Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol (1994) 1.13

Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res (1985) 1.12

Endogenous New World primate retrovirus: interspecies antigenic determinants shared with the major structural protein of type-D RNA viruses of Old World monkeys. Proc Natl Acad Sci U S A (1977) 1.09

Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res (1998) 1.09

Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol (1976) 1.06

Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gan (1984) 1.04

Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer (2001) 1.04

Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol (1994) 1.03

Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase. J Biol Chem (1999) 1.02

Effect of oxygen on heme and cytochrome content in some facultative bacteria. Enzyme (1973) 1.02

A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang (2010) 1.02

Breaking the cycle of HTLV-I transmission via carrier mothers' milk. Lancet (1987) 1.00

Three spliced mRNAs of TT virus transcribed from a plasmid containing the entire genome in COS1 cells. J Virol (2000) 0.99

Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. Lab Invest (2000) 0.98

Clinical and radiological features in four adolescents with nutcracker syndrome. Pediatr Nephrol (2000) 0.98

Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br J Cancer (1998) 0.97

Milk-borne transmission of HTLV-I from carrier mothers to their children. Jpn J Cancer Res (1987) 0.97

Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals. Jpn J Cancer Res (1992) 0.95

Deleted HTLV-1 provirus in cord-blood samples of babies born to HTLV-1-carrier mothers. Int J Cancer (1998) 0.94

Identification of a functionally important population in phenol-digesting activated sludge with antisera raised against isolated bacterial strains. Appl Environ Microbiol (1996) 0.93

Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol (1998) 0.92

Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res (1998) 0.90

Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J Am Soc Nephrol (2001) 0.88

Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis (2000) 0.88

Effects of bosentan on the skin lesions: an observational study from a single center in Japan. Rheumatol Int (2008) 0.87

RNA sequences and proteins specific to Friend strain of spleen focus-forming virus. Cold Spring Harb Symp Quant Biol (1980) 0.87

High frequency of postnatal transmission of TT virus in infancy. Arch Virol (2000) 0.87

Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics (1990) 0.86

Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol (1986) 0.86

Occult hepatitis B infection in blood donors. Vox Sang (2008) 0.86

Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr Nephrol (1997) 0.86

Relation between the tumor-specific antigen and cytological characteristics in mouse mammary tumors. J Natl Cancer Inst (1970) 0.85

Immunoprevention of x-ray-induced leukemias in the C57BL mouse. Proc Natl Acad Sci U S A (1977) 0.85

Intraparticulate localization of some peroxisomal enzymes related to fatty acid beta-oxidation. Eur J Biochem (1981) 0.84

Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results. Jpn J Cancer Res (1989) 0.84

Heparin-binding EGF-like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis. J Pathol (1999) 0.84

Mother-to-child transmission of HTLV-1. Cancer Detect Prev (1991) 0.84

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan. Vox Sang (2005) 0.84

Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease). Am J Kidney Dis (2001) 0.83

Genetic recombination between mouse type C RNA viruses: a mechanism for endogenous viral gene amplification in mammalian cells. Proc Natl Acad Sci U S A (1978) 0.83

HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet (1994) 0.83

Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability. Kidney Int (1999) 0.82

Type-C virus structural antigens on the surface of the infected cell as determined by a humoral cytotoxicity assay. Int J Cancer (1978) 0.82

Serum and monoclonal immunoglobulin E antibodies from NC/Nga mice with severe atopic-like dermatitis recognize an auto-antigen, histone H3. Clin Exp Allergy (2009) 0.81

Characteristics of a virus found in a Rous mouse cell line, SR-C3H-2127. Jpn J Exp Med (1972) 0.81

Molecular cloning, expression, and chromosomal localization of a human tubulointerstitial nephritis antigen. Biochem Biophys Res Commun (2000) 0.81

The target antigen of anti-tubular basement membrane antibody-mediated interstitial nephritis. Autoimmunity (1994) 0.81

Portal hemodynamics in chronic portal-systemic encephalopathy. Angiographic study in seven cases. J Hepatol (1985) 0.81

Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line. Br J Cancer (2002) 0.81

Milk-borne transmission of HTLV-I as a major route in the endemic cycle. Acta Paediatr Jpn (1989) 0.81

Intraoperative real-time genetic diagnosis for sentinel node navigation surgery. Int J Oral Maxillofac Surg (2004) 0.81

In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-beta stimulated clone-22. Oncol Rep (2000) 0.80

Triathlon competition induced a transient immunosuppressive change in the peripheral blood of athletes. J Sports Med Phys Fitness (1993) 0.80

Chronic portal-systemic encephalopathy with normal portal vein pressure possibly due to noncirrhotic portal fibrosis. Dig Dis Sci (1984) 0.80

Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg (2005) 0.80

Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer. Int J Oncol (2001) 0.80

Effect of time of day on adaptive response to a 4-week aerobic exercise program. J Sports Med Phys Fitness (1992) 0.80

Evolution in the hypervariable region of hepatitis C virus in infants after vertical transmission. Pediatr Res (2000) 0.80

Dependency of antibody titer on provirus load in human T lymphotropic virus type I carriers: an interpretation for the minor population of seronegative carriers. J Infect Dis (1995) 0.79

Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. Br J Cancer (1999) 0.79

Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults. Gan (1982) 0.79

Exercise-induced changes in the expression of surface adhesion molecules on circulating granulocytes and lymphocytes subpopulations. Eur J Appl Physiol Occup Physiol (1995) 0.79

Altered expression of a novel cellular gene as a consequence of integration of human T cell lymphotropic virus type 1. J Gen Virol (1994) 0.79

HTLV and the propagation of Christianity in Nagasaki. Lancet (1984) 0.78

Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines. Br J Cancer (2001) 0.78

Immobilization osteoporosis and active vitamin D: effect of active vitamin D analogs on the development of immobilization osteoporosis in rats. Calcif Tissue Int (1981) 0.78

Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor. Int J Oncol (1999) 0.78

Transfusion-mediated spread of the human T-cell leukemia virus in chronic hemodialysis patients in a heavily endemic area, Nagasaki. Gan (1984) 0.78

Proto-oncogene expression in human glomerular diseases. J Pathol (1996) 0.77

Induction of peroxisomal enzymes in rat liver by the hypolipidemic agent LK-903. Biochem Pharmacol (1981) 0.77

Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line. J Exp Clin Cancer Res (2003) 0.77

Esophageal varices: correlation of left gastric venography and endoscopy in patients with portal hypertension. Radiology (1985) 0.76

Expression of tenascin in normal and diseased human kidneys. Nihon Jinzo Gakkai Shi (1996) 0.76

Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis. Jpn J Cancer Res (1990) 0.76

Combined therapy in children and adolescents with IgA nephropathy. Nihon Jinzo Gakkai Shi (1994) 0.76

Physico-chemical properties of mouse hepatitis virus (MHV-2) grown on DBT cell culture. Microbiol Immunol (1978) 0.76

Isolation and characterization of the tubular basement membrane antigen associated with human tubulo-interstitial nephritis. Clin Exp Immunol (1992) 0.75

ATL development after adult infection of HTLV-1? Jpn J Cancer Res (1989) 0.75

[Review of this year's medical conferences--internal medicine]. Nihon Ishikai Zasshi (1965) 0.75

[Laboratory examinations in emergency cases: gastric juice test]. Naika (1965) 0.75

Report of the Fifth International Conference on Human Retrovirology: Human T-cell Lymphotropic Virus. Jpn J Clin Oncol (1993) 0.75